MrgprX2 antagonist-9 is an MRGPRX2 antagonist with an IC50 of 0.1-100 nM. MrgprX2 antagonist-9 can be used for the research of inflammatory diseases [1].
In Vitro, MrgprX2 antagonist-9 (Compound 10) inhibits human MRGPRX2 activity with an IC50 of 0.1-100 nM in a β-Arrestin assay[1].
References:
[1]. Sabnis RW, et al. Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases. ACS Med Chem Lett. 2025;16(5):732-733. Published 2025 Apr 2.
In Vitro, MrgprX2 antagonist-9 (Compound 10) inhibits human MRGPRX2 activity with an IC50 of 0.1-100 nM in a β-Arrestin assay[1].
References:
[1]. Sabnis RW, et al. Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases. ACS Med Chem Lett. 2025;16(5):732-733. Published 2025 Apr 2.
















